The Wnt5a-β-catenin Pathway Triggers a Metabolic Switch That Drives Indoleamine 2,3-dioxygenase Activity and Dendritic Cell Tolerization in the Melanoma Microenvironment.
| dc.contributor.author | Zhao, F | |
| dc.contributor.author | Evans, K | |
| dc.contributor.author | Xiao, C | |
| dc.contributor.author | Holtzhausen, A | |
| dc.contributor.author | Hanks, BA | |
| dc.coverage.spatial | National Harbor, Washington, DC | |
| dc.date.accessioned | 2017-04-13T20:36:28Z | |
| dc.date.available | 2017-04-13T20:36:28Z | |
| dc.date.issued | 2017-04-13 | |
| dc.identifier.issn | 2051-1426 | |
| dc.identifier.uri | ||
| dc.publisher | BioMed Central | |
| dc.relation.ispartof | Journal for ImmunoTherapy of Cancer | |
| dc.source | Society for Immunotherapy of Cancer 2016 Annual Meeting | |
| dc.title | The Wnt5a-β-catenin Pathway Triggers a Metabolic Switch That Drives Indoleamine 2,3-dioxygenase Activity and Dendritic Cell Tolerization in the Melanoma Microenvironment. | |
| dc.type | Conference | |
| duke.contributor.orcid | Hanks, BA|0000-0002-2803-3272|0000-0002-2803-3272 | |
| pubs.begin-page | 8 | |
| pubs.end-page | 9 | |
| pubs.finish-date | 2016-11-13 | |
| pubs.issue | 4(suppl 1) | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Duke Cancer Institute | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Medicine, Medical Oncology | |
| pubs.organisational-group | School of Medicine | |
| pubs.start-date | 2016-11-09 | |
| pubs.volume | 82 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- art_10.1186_s40425-016-0172-7.pdf
- Size:
- 8.11 MB
- Format:
- Adobe Portable Document Format